Olfr31 inhibitors encompass a range of chemical compounds that serve to diminish the functional activity of this specific olfactory receptor by affecting various points of its signaling pathway. For instance, certain compounds specifically target epithelial sodium channels, which are crucial for maintaining the ionic balance necessary for olfactory receptor functionality. Disruption of this balance can lead to the inhibition of Olfr31 by altering the electrochemical environment critical for its signaling. Moreover, the receptor's dependence on calcium signaling is a vulnerability that can be exploited by inhibitors of calcium channels. By blocking these channels, the intracellular calcium dynamics, which are integral to olfactory transduction, are disturbed, thus leading to the inhibition of the receptor's signal propagation.
Other inhibitors work by modulating the sensory neuron environment where Olfr31 operates. Antagonists of vanilloid and nicotinic acetylcholine receptors are examples of compounds that interfere with sensory perception and neuronal excitability, respectively. This interference can create an indirect inhibitory effect on Olfr31 by altering the neuronal response. Additionally, alterations in membrane fluidity and potential, triggered by chemicals affecting G-protein coupled receptors or by blocking potassium and sodium channels, can dampen the activity of the olfactory receptor. Furthermore, specific peptides and chloride channel inhibitors can impact calcium-dependent signaling processes and chloride transport, further contributing to the spectrum of mechanisms leading to the decreased activity of Olfr31.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $56.00 | 6 | |
Blocks epithelial sodium channels (ENaC). Olfr31, being an olfactory receptor, may have its signaling affected due to altered sodium ion concentrations in the olfactory epithelium leading to inhibition. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $184.00 $245.00 | 13 | |
An inhibitor of calcium channels. Olfr31 function is dependent on calcium signaling for olfactory transduction; thus, blocking these channels can inhibit signal transduction. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $145.00 $450.00 | 11 | |
A vanilloid receptor antagonist that can interfere with ion channels related to sensory perception. This may indirectly inhibit Olfr31 by altering the sensory neuron environment. | ||||||
Methyllycaconitine citrate | 112825-05-5 | sc-253043 sc-253043A | 5 mg 25 mg | $117.00 $398.00 | 2 | |
A nicotinic acetylcholine receptor antagonist that could modulate neuronal excitability and indirectly inhibit the signaling of Olfr31 by affecting the overall neuronal response. | ||||||
Tetraethylammonium chloride | 56-34-8 | sc-202834 | 25 g | $44.00 | 2 | |
A potassium channel blocker that could disrupt the neuronal membrane potential, potentially leading to reduced activity of Olfr31 as part of the olfactory signaling cascade. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
A calcium channel blocker that could inhibit intracellular calcium dynamics necessary for Olfr31 signaling within the olfactory transduction pathway. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $63.00 $173.00 | 7 | |
A chemical that can inhibit calcium channels and may indirectly inhibit Olfr31, given its reliance on calcium for signal transduction. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $31.00 | 3 | |
An inhibitor of chloride channels, which may influence the olfactory signal transduction process, thereby indirectly inhibiting Olfr31 activity. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $200.00 | 2 | |
A muscarinic acetylcholine receptor antagonist which, by modulating parasympathetic activity, could influence the olfactory system and indirectly inhibit Olfr31. | ||||||